OSTIN TECHNOLOGY GROUP CO LT (OST)

KYG679271067 - Common Stock

0.1779  +0 (+0.11%)

After market: 0.1806 +0 (+1.52%)

Fundamental Rating

0

Overall OST gets a fundamental rating of 0 out of 10. We evaluated OST against 127 industry peers in the Electronic Equipment, Instruments & Components industry. OST may be in some trouble as it scores bad on both profitability and health. OST does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

OST had negative earnings in the past year.
In the past year OST has reported a negative cash flow from operations.
OST had positive earnings in 4 of the past 5 years.
In multiple years OST reported negative operating cash flow during the last 5 years.

1.2 Ratios

OST's Return On Assets of -30.31% is on the low side compared to the rest of the industry. OST is outperformed by 79.20% of its industry peers.
Looking at the Return On Equity, with a value of -151.59%, OST is doing worse than 89.60% of the companies in the same industry.
Industry RankSector Rank
ROA -30.31%
ROE -151.59%
ROIC N/A
ROA(3y)-4.98%
ROA(5y)-1.7%
ROE(3y)-18.67%
ROE(5y)-3.9%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of OST (4.06%) is worse than 90.40% of its industry peers.
In the last couple of years the Gross Margin of OST has declined.
The Profit Margin and Operating Margin are not available for OST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 4.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.45%
GM growth 5Y-13.37%

0

2. Health

2.1 Basic Checks

OST does not have a ROIC to compare to the WACC, probably because it is not profitable.
OST has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for OST remains at a similar level compared to 5 years ago.
OST has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -0.20, we must say that OST is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of OST (-0.20) is worse than 79.20% of its industry peers.
A Debt/Equity ratio of 2.61 is on the high side and indicates that OST has dependencies on debt financing.
With a Debt to Equity ratio value of 2.61, OST is not doing good in the industry: 96.80% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.61
Debt/FCF N/A
Altman-Z -0.2
ROIC/WACCN/A
WACC4.67%

2.3 Liquidity

OST has a Current Ratio of 0.54. This is a bad value and indicates that OST is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.54, OST is doing worse than 96.80% of the companies in the same industry.
OST has a Quick Ratio of 0.54. This is a bad value and indicates that OST is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.25, OST is doing worse than 98.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.25

0

3. Growth

3.1 Past

The earnings per share for OST have decreased strongly by -216.71% in the last year.
The Revenue for OST has decreased by -48.11% in the past year. This is quite bad
OST shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.33% yearly.
EPS 1Y (TTM)-216.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.77%
Revenue 1Y (TTM)-48.11%
Revenue growth 3Y-25.67%
Revenue growth 5Y-1.33%
Sales Q2Q%-56.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

OST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

OST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OSTIN TECHNOLOGY GROUP CO LT

NASDAQ:OST (12/20/2024, 8:00:02 PM)

After market: 0.1806 +0 (+1.52%)

0.1779

+0 (+0.11%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11 2024-02-11
Earnings (Next)N/A N/A
Inst Owners0.28%
Inst Owner Change28.75%
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap2.99M
AnalystsN/A
Price TargetN/A
Short Float %0.63%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.72
EV/EBITDA N/A
EPS(TTM)-1.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS4.31
BVpS0.61
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.31%
ROE -151.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 4.06%
FCFM N/A
ROA(3y)-4.98%
ROA(5y)-1.7%
ROE(3y)-18.67%
ROE(5y)-3.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.45%
GM growth 5Y-13.37%
F-Score1
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 2.61
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 89.58%
Cap/Sales 4.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.25
Altman-Z -0.2
F-Score1
WACC4.67%
ROIC/WACCN/A
Cap/Depr(3y)283.87%
Cap/Depr(5y)446.35%
Cap/Sales(3y)8.17%
Cap/Sales(5y)8.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-216.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-48.11%
Revenue growth 3Y-25.67%
Revenue growth 5Y-1.33%
Sales Q2Q%-56.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-156.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.01%
OCF growth 3YN/A
OCF growth 5YN/A